Novel motif:43
From FANTOM5_SSTAR
name: | motif43_CCCWGT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006955 | immune response | 1.652121e-30 |
GO:0006952 | defense response | 4.095253e-28 |
GO:0006954 | inflammatory response | 3.896688e-20 |
GO:0071732 | cellular response to nitric oxide | 4.021675e-19 |
GO:0002376 | immune system process | 5.637123e-18 |
GO:0045087 | innate immune response | 5.364561e-16 |
GO:0071731 | response to nitric oxide | 1.095755e-13 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.725644e-13 |
GO:0034340 | response to type I interferon | 2.088184e-13 |
GO:0060337 | type I interferon-mediated signaling pathway | 2.147029e-13 |
GO:0008078 | mesodermal cell migration | 1.278854e-12 |
GO:0002682 | regulation of immune system process | 1.491119e-12 |
GO:0009612 | response to mechanical stimulus | 1.653626e-12 |
GO:0009605 | response to external stimulus | 6.552023e-12 |
GO:0010033 | response to organic substance | 8.628763e-12 |
GO:0070849 | response to epidermal growth factor stimulus | 9.490442e-12 |
GO:0007586 | digestion | 1.081475e-11 |
GO:0035814 | negative regulation of renal sodium excretion | 1.485814e-11 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 4.271018e-11 |
GO:0001817 | regulation of cytokine production | 4.983770e-11 |
GO:0050896 | response to stimulus | 7.045515e-11 |
GO:0042424 | catecholamine catabolic process | 9.454898e-11 |
GO:0010941 | regulation of cell death | 1.071641e-10 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.417967e-10 |
GO:0019221 | cytokine-mediated signaling pathway | 2.433345e-10 |
GO:0002443 | leukocyte mediated immunity | 2.524107e-10 |
GO:0030185 | nitric oxide transport | 2.783750e-10 |
GO:0022617 | extracellular matrix disassembly | 3.750144e-10 |
GO:0010243 | response to organic nitrogen | 4.868484e-10 |
GO:0030010 | establishment of cell polarity | 5.250875e-10 |
GO:0001101 | response to acid | 7.114715e-10 |
GO:0031960 | response to corticosteroid stimulus | 1.056492e-9 |
GO:0051707 | response to other organism | 1.296504e-9 |
GO:0060290 | transdifferentiation | 1.328773e-9 |
GO:0002684 | positive regulation of immune system process | 1.392838e-9 |
GO:0032203 | telomere formation via telomerase | 1.549575e-9 |
GO:0009607 | response to biotic stimulus | 2.130538e-9 |
GO:0043200 | response to amino acid stimulus | 2.155669e-9 |
GO:0033986 | response to methanol | 2.211935e-9 |
GO:0046687 | response to chromate | 2.211935e-9 |
GO:0048545 | response to steroid hormone stimulus | 2.354199e-9 |
GO:0000302 | response to reactive oxygen species | 2.618237e-9 |
GO:0045026 | plasma membrane fusion | 2.674615e-9 |
GO:0048584 | positive regulation of response to stimulus | 2.752980e-9 |
GO:0042981 | regulation of apoptosis | 3.502706e-9 |
GO:0043067 | regulation of programmed cell death | 3.538055e-9 |
GO:0071417 | cellular response to organic nitrogen | 4.115900e-9 |
GO:0034014 | response to triglyceride | 4.543619e-9 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 5.945344e-9 |
GO:0007585 | respiratory gaseous exchange | 9.212380e-9 |
GO:0065008 | regulation of biological quality | 9.548626e-9 |
GO:0009253 | peptidoglycan catabolic process | 1.024466e-8 |
GO:0009611 | response to wounding | 1.137546e-8 |
GO:0044281 | small molecule metabolic process | 1.180278e-8 |
GO:0008610 | lipid biosynthetic process | 1.243957e-8 |
GO:0071418 | cellular response to amine stimulus | 1.319913e-8 |
GO:0007154 | cell communication | 1.378893e-8 |
GO:0009628 | response to abiotic stimulus | 1.532083e-8 |
GO:0019882 | antigen processing and presentation | 1.546051e-8 |
GO:0001819 | positive regulation of cytokine production | 1.583968e-8 |
GO:0023052 | signaling | 1.756279e-8 |
GO:0045834 | positive regulation of lipid metabolic process | 1.940467e-8 |
GO:0042420 | dopamine catabolic process | 2.217878e-8 |
GO:0071260 | cellular response to mechanical stimulus | 2.342687e-8 |
GO:0009719 | response to endogenous stimulus | 2.429291e-8 |
GO:0010872 | regulation of cholesterol esterification | 2.473828e-8 |
GO:0016064 | immunoglobulin mediated immune response | 2.526981e-8 |
GO:0070417 | cellular response to cold | 2.709066e-8 |
GO:0002449 | lymphocyte mediated immunity | 3.313638e-8 |
GO:0042592 | homeostatic process | 3.973593e-8 |
GO:0071230 | cellular response to amino acid stimulus | 4.105974e-8 |
GO:0034097 | response to cytokine stimulus | 4.304087e-8 |
GO:0046902 | regulation of mitochondrial membrane permeability | 4.590053e-8 |
GO:0050776 | regulation of immune response | 4.753600e-8 |
GO:0044255 | cellular lipid metabolic process | 5.261144e-8 |
GO:0006342 | chromatin silencing | 5.527642e-8 |
GO:0007568 | aging | 5.566104e-8 |
GO:0006629 | lipid metabolic process | 5.802416e-8 |
GO:0016052 | carbohydrate catabolic process | 6.015702e-8 |
GO:0002237 | response to molecule of bacterial origin | 6.558806e-8 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 6.851869e-8 |
GO:0014075 | response to amine stimulus | 7.281177e-8 |
GO:0044283 | small molecule biosynthetic process | 7.441396e-8 |
GO:0009966 | regulation of signal transduction | 7.941366e-8 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 7.962685e-8 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 8.821362e-8 |
GO:0019724 | B cell mediated immunity | 8.916804e-8 |
GO:0042221 | response to chemical stimulus | 9.706334e-8 |
GO:0048583 | regulation of response to stimulus | 9.919739e-8 |
GO:0006022 | aminoglycan metabolic process | 1.009513e-7 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.085852e-7 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 1.088525e-7 |
GO:0042542 | response to hydrogen peroxide | 1.233364e-7 |
GO:0032496 | response to lipopolysaccharide | 1.233427e-7 |
GO:0071229 | cellular response to acid | 1.265087e-7 |
GO:0006909 | phagocytosis | 1.345459e-7 |
GO:0045471 | response to ethanol | 1.359773e-7 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.378605e-7 |
GO:0007342 | fusion of sperm to egg plasma membrane | 1.384678e-7 |
GO:0045940 | positive regulation of steroid metabolic process | 1.517341e-7 |
GO:0048519 | negative regulation of biological process | 1.557539e-7 |
GO:0090130 | tissue migration | 1.560016e-7 |
GO:0021984 | adenohypophysis development | 1.815782e-7 |
GO:0010873 | positive regulation of cholesterol esterification | 1.850478e-7 |
GO:0044062 | regulation of excretion | 1.856744e-7 |
GO:0007165 | signal transduction | 1.886331e-7 |
GO:0002252 | immune effector process | 1.922591e-7 |
GO:0051384 | response to glucocorticoid stimulus | 2.181515e-7 |
GO:0051704 | multi-organism process | 2.253935e-7 |
GO:0023051 | regulation of signaling | 2.318176e-7 |
GO:0035813 | regulation of renal sodium excretion | 2.345266e-7 |
GO:0007166 | cell surface receptor linked signaling pathway | 2.397883e-7 |
GO:0045814 | negative regulation of gene expression, epigenetic | 2.647845e-7 |
GO:0009895 | negative regulation of catabolic process | 2.750406e-7 |
GO:0033189 | response to vitamin A | 2.974651e-7 |
GO:0006631 | fatty acid metabolic process | 3.285192e-7 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 3.361947e-7 |
GO:0009967 | positive regulation of signal transduction | 3.426060e-7 |
GO:0006953 | acute-phase response | 3.701151e-7 |
GO:0044236 | multicellular organismal metabolic process | 4.423180e-7 |
GO:0090218 | positive regulation of lipid kinase activity | 4.557392e-7 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 4.851528e-7 |
GO:0015671 | oxygen transport | 5.275926e-7 |
GO:0002253 | activation of immune response | 5.297234e-7 |
GO:0031667 | response to nutrient levels | 5.462092e-7 |
GO:0045730 | respiratory burst | 5.579041e-7 |
GO:0032910 | regulation of transforming growth factor beta3 production | 5.840366e-7 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 6.267023e-7 |
GO:0032012 | regulation of ARF protein signal transduction | 6.303864e-7 |
GO:0008284 | positive regulation of cell proliferation | 6.388992e-7 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 6.442028e-7 |
GO:0009991 | response to extracellular stimulus | 6.445842e-7 |
GO:0002526 | acute inflammatory response | 6.668088e-7 |
GO:0051937 | catecholamine transport | 6.710474e-7 |
GO:0002250 | adaptive immune response | 6.922626e-7 |
GO:0046164 | alcohol catabolic process | 7.237629e-7 |
GO:0002579 | positive regulation of antigen processing and presentation | 7.664862e-7 |
GO:0048878 | chemical homeostasis | 7.922084e-7 |
GO:0032202 | telomere assembly | 8.153405e-7 |
GO:0019321 | pentose metabolic process | 8.729189e-7 |
GO:0043086 | negative regulation of catalytic activity | 8.924141e-7 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.011173e-6 |
GO:0060548 | negative regulation of cell death | 1.076514e-6 |
GO:0060326 | cell chemotaxis | 1.077413e-6 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.125697e-6 |
GO:0015844 | monoamine transport | 1.257819e-6 |
GO:0050830 | defense response to Gram-positive bacterium | 1.324297e-6 |
GO:0043066 | negative regulation of apoptosis | 1.454586e-6 |
GO:0051591 | response to cAMP | 1.455213e-6 |
GO:0050778 | positive regulation of immune response | 1.520338e-6 |
GO:0033273 | response to vitamin | 1.631864e-6 |
GO:0018208 | peptidyl-proline modification | 1.666935e-6 |
GO:0001880 | Mullerian duct regression | 1.728783e-6 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.750948e-6 |
GO:0046949 | fatty-acyl-CoA biosynthetic process | 1.773796e-6 |
GO:0048518 | positive regulation of biological process | 1.806493e-6 |
GO:0051291 | protein heterooligomerization | 1.811911e-6 |
GO:0032787 | monocarboxylic acid metabolic process | 2.097913e-6 |
GO:0046394 | carboxylic acid biosynthetic process | 2.254793e-6 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 2.326754e-6 |
GO:0010897 | negative regulation of triglyceride catabolic process | 2.326754e-6 |
GO:0002251 | organ or tissue specific immune response | 2.396644e-6 |
GO:0060696 | regulation of phospholipid catabolic process | 2.437890e-6 |
GO:0046314 | phosphocreatine biosynthetic process | 2.459085e-6 |
GO:0015669 | gas transport | 2.500515e-6 |
GO:0021858 | GABAergic neuron differentiation in basal ganglia | 2.682427e-6 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 2.682427e-6 |
GO:0032094 | response to food | 2.787378e-6 |
GO:0007163 | establishment or maintenance of cell polarity | 2.873643e-6 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 2.935325e-6 |
GO:0071345 | cellular response to cytokine stimulus | 2.968650e-6 |
GO:0007006 | mitochondrial membrane organization | 3.070076e-6 |
GO:0042396 | phosphagen biosynthetic process | 3.190794e-6 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 3.457573e-6 |
GO:0048247 | lymphocyte chemotaxis | 3.507533e-6 |
GO:0034505 | tooth mineralization | 3.571496e-6 |
GO:0045338 | farnesyl diphosphate metabolic process | 3.635070e-6 |
GO:0010875 | positive regulation of cholesterol efflux | 3.670155e-6 |
GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process | 3.719076e-6 |
GO:0032663 | regulation of interleukin-2 production | 3.800281e-6 |
GO:0016458 | gene silencing | 3.909074e-6 |
GO:0010646 | regulation of cell communication | 3.979804e-6 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 4.017826e-6 |
GO:0000920 | cytokinetic cell separation | 4.023909e-6 |
GO:0051179 | localization | 4.221191e-6 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 4.377345e-6 |
GO:0006950 | response to stress | 4.401587e-6 |
GO:0043069 | negative regulation of programmed cell death | 4.402288e-6 |
GO:0048352 | paraxial mesoderm structural organization | 4.779123e-6 |
GO:0021998 | neural plate mediolateral regionalization | 4.779123e-6 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 4.789581e-6 |
GO:0072132 | mesenchyme morphogenesis | 4.832931e-6 |
GO:0031330 | negative regulation of cellular catabolic process | 4.915752e-6 |
GO:0006026 | aminoglycan catabolic process | 5.111862e-6 |
GO:0008217 | regulation of blood pressure | 5.326454e-6 |
GO:0007296 | vitellogenesis | 5.370399e-6 |
GO:0019048 | virus-host interaction | 5.469477e-6 |
GO:0019049 | evasion of host defenses by virus | 5.647848e-6 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 5.702601e-6 |
GO:0007183 | SMAD protein complex assembly | 5.715289e-6 |
GO:0044258 | intestinal lipid catabolic process | 5.757193e-6 |
GO:0018350 | protein esterification | 5.757193e-6 |
GO:0009725 | response to hormone stimulus | 5.802229e-6 |
GO:0051220 | cytoplasmic sequestering of protein | 5.918852e-6 |
GO:0044341 | sodium-dependent phosphate transport | 6.043521e-6 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 6.178290e-6 |
GO:0048535 | lymph node development | 6.329797e-6 |
GO:0045806 | negative regulation of endocytosis | 6.735740e-6 |
GO:0044092 | negative regulation of molecular function | 6.754142e-6 |
GO:0034201 | response to oleic acid | 6.953020e-6 |
GO:0048255 | mRNA stabilization | 7.586309e-6 |
GO:0043550 | regulation of lipid kinase activity | 7.656723e-6 |
GO:0043300 | regulation of leukocyte degranulation | 7.826255e-6 |
GO:0009617 | response to bacterium | 8.003408e-6 |
GO:0070887 | cellular response to chemical stimulus | 8.171981e-6 |
GO:0042177 | negative regulation of protein catabolic process | 8.255342e-6 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 8.639942e-6 |
GO:0048002 | antigen processing and presentation of peptide antigen | 8.671565e-6 |
GO:0006007 | glucose catabolic process | 8.919209e-6 |
GO:0030203 | glycosaminoglycan metabolic process | 9.562559e-6 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.095948e-5 |
GO:0034341 | response to interferon-gamma | 1.128572e-5 |
GO:0050764 | regulation of phagocytosis | 1.137319e-5 |
GO:0060644 | mammary gland epithelial cell differentiation | 1.138260e-5 |
GO:0016044 | cellular membrane organization | 1.157618e-5 |
GO:0050865 | regulation of cell activation | 1.181366e-5 |
GO:0014070 | response to organic cyclic compound | 1.190742e-5 |
GO:0061180 | mammary gland epithelium development | 1.253580e-5 |
GO:0051051 | negative regulation of transport | 1.262983e-5 |
GO:0051239 | regulation of multicellular organismal process | 1.277584e-5 |
GO:0006916 | anti-apoptosis | 1.363224e-5 |
GO:0050832 | defense response to fungus | 1.369263e-5 |
GO:0061024 | membrane organization | 1.371450e-5 |
GO:0044130 | negative regulation of growth of symbiont in host | 1.440628e-5 |
GO:0046514 | ceramide catabolic process | 1.470577e-5 |
GO:0007109 | cytokinesis, completion of separation | 1.484489e-5 |
GO:0002694 | regulation of leukocyte activation | 1.489274e-5 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.527109e-5 |
GO:0002679 | respiratory burst involved in defense response | 1.547188e-5 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 1.685259e-5 |
GO:0051251 | positive regulation of lymphocyte activation | 1.725134e-5 |
GO:0071705 | nitrogen compound transport | 1.777953e-5 |
GO:0002098 | tRNA wobble uridine modification | 1.807152e-5 |
GO:0034227 | tRNA thio-modification | 1.807152e-5 |
GO:0051246 | regulation of protein metabolic process | 1.852091e-5 |
GO:0006014 | D-ribose metabolic process | 1.885730e-5 |
GO:0006810 | transport | 2.003996e-5 |
GO:0044275 | cellular carbohydrate catabolic process | 2.077662e-5 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.142860e-5 |
GO:0007259 | JAK-STAT cascade | 2.214696e-5 |
GO:0010627 | regulation of intracellular protein kinase cascade | 2.221355e-5 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 2.272082e-5 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 2.286713e-5 |
GO:0019432 | triglyceride biosynthetic process | 2.345215e-5 |
GO:0043304 | regulation of mast cell degranulation | 2.433927e-5 |
GO:0071299 | cellular response to vitamin A | 2.486495e-5 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 2.526252e-5 |
GO:0051249 | regulation of lymphocyte activation | 2.530670e-5 |
GO:0002764 | immune response-regulating signaling pathway | 2.545553e-5 |
GO:0006633 | fatty acid biosynthetic process | 2.785801e-5 |
GO:0007000 | nucleolus organization | 2.786374e-5 |
GO:0051234 | establishment of localization | 2.792335e-5 |
GO:0051716 | cellular response to stimulus | 2.863955e-5 |
GO:0008366 | axon ensheathment | 2.869295e-5 |
GO:0050801 | ion homeostasis | 2.912887e-5 |
GO:0042552 | myelination | 3.087930e-5 |
GO:0050848 | regulation of calcium-mediated signaling | 3.088364e-5 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 3.147790e-5 |
GO:0016126 | sterol biosynthetic process | 3.174429e-5 |
GO:0003218 | cardiac left ventricle formation | 3.185392e-5 |
GO:0042127 | regulation of cell proliferation | 3.239183e-5 |
GO:0030595 | leukocyte chemotaxis | 3.243420e-5 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 3.253105e-5 |
GO:0006082 | organic acid metabolic process | 3.266166e-5 |
GO:0033211 | adiponectin-mediated signaling pathway | 3.274089e-5 |
GO:0003334 | keratinocyte development | 3.546165e-5 |
GO:0032963 | collagen metabolic process | 3.574963e-5 |
GO:0070542 | response to fatty acid | 3.579374e-5 |
GO:0019320 | hexose catabolic process | 3.589485e-5 |
GO:0050829 | defense response to Gram-negative bacterium | 3.608058e-5 |
GO:0006690 | icosanoid metabolic process | 3.621636e-5 |
GO:0032964 | collagen biosynthetic process | 3.649405e-5 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 3.709597e-5 |
GO:0055080 | cation homeostasis | 3.832381e-5 |
GO:0022009 | central nervous system vasculogenesis | 3.846092e-5 |
GO:0071346 | cellular response to interferon-gamma | 3.911767e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 4.101710e-5 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 4.111558e-5 |
GO:0002218 | activation of innate immune response | 4.176824e-5 |
GO:0006544 | glycine metabolic process | 4.233203e-5 |
GO:0032879 | regulation of localization | 4.391366e-5 |
GO:0071300 | cellular response to retinoic acid | 4.430595e-5 |
GO:0015937 | coenzyme A biosynthetic process | 4.474868e-5 |
GO:0030913 | paranodal junction assembly | 4.540937e-5 |
GO:0060346 | bone trabecula formation | 4.557413e-5 |
GO:0043249 | erythrocyte maturation | 4.609843e-5 |
GO:0033559 | unsaturated fatty acid metabolic process | 4.674271e-5 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 4.729695e-5 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 5.006637e-5 |
GO:0042398 | cellular modified amino acid biosynthetic process | 5.069568e-5 |
GO:0009308 | amine metabolic process | 5.086486e-5 |
GO:0001973 | adenosine receptor signaling pathway | 5.122472e-5 |
GO:0033993 | response to lipid | 5.298226e-5 |
GO:0031347 | regulation of defense response | 5.333270e-5 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 5.360647e-5 |
GO:0010888 | negative regulation of lipid storage | 5.368927e-5 |
GO:0010647 | positive regulation of cell communication | 5.448616e-5 |
GO:0046320 | regulation of fatty acid oxidation | 5.548234e-5 |
GO:0006637 | acyl-CoA metabolic process | 5.568198e-5 |
GO:0002828 | regulation of type 2 immune response | 5.609456e-5 |
GO:0009583 | detection of light stimulus | 5.634541e-5 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.693077e-5 |
GO:0071391 | cellular response to estrogen stimulus | 5.904605e-5 |
GO:0071214 | cellular response to abiotic stimulus | 5.988964e-5 |
GO:0046365 | monosaccharide catabolic process | 6.114916e-5 |
GO:0042133 | neurotransmitter metabolic process | 6.119011e-5 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 6.387728e-5 |
GO:0046502 | uroporphyrinogen III metabolic process | 6.452219e-5 |
GO:0046128 | purine ribonucleoside metabolic process | 6.468256e-5 |
GO:0019216 | regulation of lipid metabolic process | 6.656035e-5 |
GO:0046007 | negative regulation of activated T cell proliferation | 6.701762e-5 |
GO:0002523 | leukocyte migration involved in inflammatory response | 6.701762e-5 |
GO:0046822 | regulation of nucleocytoplasmic transport | 6.844480e-5 |
GO:0008063 | Toll signaling pathway | 6.855966e-5 |
GO:0035556 | intracellular signal transduction | 6.886191e-5 |
GO:0006692 | prostanoid metabolic process | 6.935521e-5 |
GO:0032526 | response to retinoic acid | 6.990359e-5 |
GO:0050900 | leukocyte migration | 7.033032e-5 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 7.056392e-5 |
GO:0002921 | negative regulation of humoral immune response | 7.158484e-5 |
GO:0009414 | response to water deprivation | 7.194135e-5 |
GO:0015872 | dopamine transport | 7.293736e-5 |
GO:0032456 | endocytic recycling | 7.310016e-5 |
GO:0032506 | cytokinetic process | 7.356134e-5 |
GO:0015840 | urea transport | 7.356134e-5 |
GO:0007584 | response to nutrient | 7.359255e-5 |
GO:0002432 | granuloma formation | 7.435962e-5 |
GO:0061383 | trabecula morphogenesis | 7.437759e-5 |
GO:0022415 | viral reproductive process | 7.448263e-5 |
GO:0032376 | positive regulation of cholesterol transport | 7.464553e-5 |
GO:0030334 | regulation of cell migration | 7.529867e-5 |
GO:0009416 | response to light stimulus | 7.629519e-5 |
GO:0023056 | positive regulation of signaling | 7.677213e-5 |
GO:0042942 | D-serine transport | 7.999909e-5 |
GO:0030953 | astral microtubule organization | 8.025650e-5 |
GO:0030198 | extracellular matrix organization | 8.383076e-5 |
GO:0044241 | lipid digestion | 8.447860e-5 |
GO:0042278 | purine nucleoside metabolic process | 8.639382e-5 |
GO:0010740 | positive regulation of intracellular protein kinase cascade | 8.667486e-5 |
GO:0048710 | regulation of astrocyte differentiation | 8.701949e-5 |
GO:0060708 | spongiotrophoblast differentiation | 8.849894e-5 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 9.201612e-5 |
GO:0006032 | chitin catabolic process | 9.209446e-5 |
GO:0001300 | chronological cell aging | 9.244550e-5 |
GO:0007263 | nitric oxide mediated signal transduction | 9.314380e-5 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 9.379841e-5 |
GO:0000132 | establishment of mitotic spindle orientation | 9.411050e-5 |
GO:0060749 | mammary gland alveolus development | 9.421941e-5 |
GO:0018193 | peptidyl-amino acid modification | 9.491506e-5 |
GO:0065007 | biological regulation | 9.653199e-5 |
GO:0055085 | transmembrane transport | 9.669214e-5 |
GO:0050863 | regulation of T cell activation | 9.675177e-5 |
GO:0050867 | positive regulation of cell activation | 9.913526e-5 |
GO:0010824 | regulation of centrosome duplication | 1.010269e-4 |
GO:0060973 | cell migration involved in heart development | 1.036462e-4 |
GO:0009306 | protein secretion | 1.046425e-4 |
GO:0045088 | regulation of innate immune response | 1.048431e-4 |
GO:0006695 | cholesterol biosynthetic process | 1.061933e-4 |
GO:0016139 | glycoside catabolic process | 1.080042e-4 |
GO:0045651 | positive regulation of macrophage differentiation | 1.127633e-4 |
GO:0016137 | glycoside metabolic process | 1.177171e-4 |
GO:0002696 | positive regulation of leukocyte activation | 1.189015e-4 |
GO:0006662 | glycerol ether metabolic process | 1.197755e-4 |
GO:0070208 | protein heterotrimerization | 1.215083e-4 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.215324e-4 |
GO:0001957 | intramembranous ossification | 1.239946e-4 |
GO:0071383 | cellular response to steroid hormone stimulus | 1.241952e-4 |
GO:0048241 | epinephrine transport | 1.254929e-4 |
GO:0006400 | tRNA modification | 1.261093e-4 |
GO:0014829 | vascular smooth muscle contraction | 1.261254e-4 |
GO:0072593 | reactive oxygen species metabolic process | 1.263061e-4 |
GO:0006720 | isoprenoid metabolic process | 1.266542e-4 |
GO:0015879 | carnitine transport | 1.276744e-4 |
GO:2000145 | regulation of cell motility | 1.276855e-4 |
GO:0042440 | pigment metabolic process | 1.287658e-4 |
GO:0032312 | regulation of ARF GTPase activity | 1.291971e-4 |
GO:0032703 | negative regulation of interleukin-2 production | 1.301156e-4 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 1.321258e-4 |
GO:0031133 | regulation of axon diameter | 1.332503e-4 |
GO:0060480 | lung goblet cell differentiation | 1.344951e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 1.361133e-4 |
GO:0032880 | regulation of protein localization | 1.365655e-4 |
GO:0002513 | tolerance induction to self antigen | 1.417941e-4 |
GO:0046434 | organophosphate catabolic process | 1.455441e-4 |
GO:0000090 | mitotic anaphase | 1.455441e-4 |
GO:0060482 | lobar bronchus development | 1.461502e-4 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.477548e-4 |
GO:0046483 | heterocycle metabolic process | 1.493719e-4 |
GO:0046730 | induction of host immune response by virus | 1.499326e-4 |
GO:0046456 | icosanoid biosynthetic process | 1.514173e-4 |
GO:0034763 | negative regulation of transmembrane transport | 1.526616e-4 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 1.541011e-4 |
GO:0043407 | negative regulation of MAP kinase activity | 1.556631e-4 |
GO:0042744 | hydrogen peroxide catabolic process | 1.565299e-4 |
GO:0042454 | ribonucleoside catabolic process | 1.627090e-4 |
GO:0032288 | myelin assembly | 1.650870e-4 |
GO:0032740 | positive regulation of interleukin-17 production | 1.654934e-4 |
GO:0048523 | negative regulation of cellular process | 1.675146e-4 |
GO:0009749 | response to glucose stimulus | 1.679237e-4 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 1.688430e-4 |
GO:0046504 | glycerol ether biosynthetic process | 1.704397e-4 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 1.718269e-4 |
GO:0035411 | catenin import into nucleus | 1.725079e-4 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 1.764646e-4 |
GO:0019752 | carboxylic acid metabolic process | 1.781015e-4 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 1.792469e-4 |
GO:0042493 | response to drug | 1.853296e-4 |
GO:0008065 | establishment of blood-nerve barrier | 1.867633e-4 |
GO:0051241 | negative regulation of multicellular organismal process | 1.873017e-4 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 1.888479e-4 |
GO:0060620 | regulation of cholesterol import | 1.920634e-4 |
GO:0009259 | ribonucleotide metabolic process | 1.943799e-4 |
GO:0000089 | mitotic metaphase | 1.944685e-4 |
GO:0009150 | purine ribonucleotide metabolic process | 1.976124e-4 |
GO:0006740 | NADPH regeneration | 1.986081e-4 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.990593e-4 |
GO:0060659 | nipple sheath formation | 2.062749e-4 |
GO:0060649 | mammary gland bud elongation | 2.062749e-4 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 2.086847e-4 |
GO:0006766 | vitamin metabolic process | 2.113609e-4 |
GO:0060712 | spongiotrophoblast layer development | 2.122754e-4 |
GO:0048477 | oogenesis | 2.129522e-4 |
GO:0034142 | toll-like receptor 4 signaling pathway | 2.134356e-4 |
GO:0043301 | negative regulation of leukocyte degranulation | 2.134407e-4 |
GO:0006959 | humoral immune response | 2.199690e-4 |
GO:0014910 | regulation of smooth muscle cell migration | 2.239282e-4 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 2.251383e-4 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 2.264192e-4 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 2.272410e-4 |
GO:0060343 | trabecula formation | 2.286054e-4 |
GO:0009119 | ribonucleoside metabolic process | 2.290662e-4 |
GO:0070201 | regulation of establishment of protein localization | 2.304762e-4 |
GO:0060341 | regulation of cellular localization | 2.319392e-4 |
GO:0043206 | fibril organization | 2.324826e-4 |
GO:0060980 | cell migration involved in coronary vasculogenesis | 2.412641e-4 |
GO:0051973 | positive regulation of telomerase activity | 2.435765e-4 |
GO:0016090 | prenol metabolic process | 2.435765e-4 |
GO:2000147 | positive regulation of cell motility | 2.481681e-4 |
GO:0009309 | amine biosynthetic process | 2.490622e-4 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 2.492108e-4 |
GO:0002920 | regulation of humoral immune response | 2.541322e-4 |
GO:0071310 | cellular response to organic substance | 2.543121e-4 |
GO:0050790 | regulation of catalytic activity | 2.566460e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.574366e-4 |
GO:0040007 | growth | 2.601861e-4 |
GO:0045351 | type I interferon biosynthetic process | 2.615792e-4 |
GO:0072521 | purine-containing compound metabolic process | 2.643053e-4 |
GO:0071294 | cellular response to zinc ion | 2.649328e-4 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 2.658936e-4 |
GO:0034767 | positive regulation of ion transmembrane transport | 2.658936e-4 |
GO:0006098 | pentose-phosphate shunt | 2.689430e-4 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 2.697173e-4 |
GO:0060621 | negative regulation of cholesterol import | 2.714283e-4 |
GO:0048771 | tissue remodeling | 2.720660e-4 |
GO:0046165 | alcohol biosynthetic process | 2.722755e-4 |
GO:0009620 | response to fungus | 2.728061e-4 |
GO:0042180 | cellular ketone metabolic process | 2.739746e-4 |
GO:0042136 | neurotransmitter biosynthetic process | 2.751787e-4 |
GO:0051347 | positive regulation of transferase activity | 2.775167e-4 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 2.777146e-4 |
GO:0072376 | protein activation cascade | 2.829907e-4 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 2.855873e-4 |
GO:0051972 | regulation of telomerase activity | 2.863623e-4 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 2.863919e-4 |
GO:0044243 | multicellular organismal catabolic process | 2.864224e-4 |
GO:0034134 | toll-like receptor 2 signaling pathway | 2.865879e-4 |
GO:0034130 | toll-like receptor 1 signaling pathway | 2.865879e-4 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 2.923157e-4 |
GO:0048522 | positive regulation of cellular process | 2.975880e-4 |
GO:0046364 | monosaccharide biosynthetic process | 2.979944e-4 |
GO:0006754 | ATP biosynthetic process | 3.027021e-4 |
GO:0043901 | negative regulation of multi-organism process | 3.070836e-4 |
GO:0032845 | negative regulation of homeostatic process | 3.118456e-4 |
GO:0009301 | snRNA transcription | 3.149015e-4 |
GO:0006739 | NADP metabolic process | 3.161057e-4 |
GO:0060576 | intestinal epithelial cell development | 3.166321e-4 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 3.183747e-4 |
GO:0045777 | positive regulation of blood pressure | 3.196273e-4 |
GO:0032495 | response to muramyl dipeptide | 3.198215e-4 |
GO:0001661 | conditioned taste aversion | 3.202996e-4 |
GO:0006110 | regulation of glycolysis | 3.296436e-4 |
GO:0006812 | cation transport | 3.297637e-4 |
GO:0050663 | cytokine secretion | 3.313454e-4 |
GO:0032536 | regulation of cell projection size | 3.346072e-4 |
GO:0055072 | iron ion homeostasis | 3.360684e-4 |
GO:0048382 | mesendoderm development | 3.363537e-4 |
GO:0007602 | phototransduction | 3.448139e-4 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 3.454013e-4 |
GO:0010951 | negative regulation of endopeptidase activity | 3.458777e-4 |
GO:0003417 | growth plate cartilage development | 3.474499e-4 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0002739 | regulation of cytokine secretion involved in immune response | 1.625587e-10 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 4.393675e-10 |
GO:0060621 | negative regulation of cholesterol import | 6.036169e-10 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 8.271525e-10 |
GO:0009214 | cyclic nucleotide catabolic process | 1.142667e-9 |
GO:0010033 | response to organic substance | 1.971380e-9 |
GO:0060620 | regulation of cholesterol import | 2.332433e-9 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 2.564271e-9 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 3.556924e-9 |
GO:0060907 | positive regulation of macrophage cytokine production | 4.740162e-9 |
GO:0032103 | positive regulation of response to external stimulus | 7.324866e-9 |
GO:0009125 | nucleoside monophosphate catabolic process | 7.377837e-9 |
GO:0002687 | positive regulation of leukocyte migration | 8.606994e-9 |
GO:0002718 | regulation of cytokine production involved in immune response | 1.166280e-8 |
GO:0006518 | peptide metabolic process | 1.283861e-8 |
GO:0043647 | inositol phosphate metabolic process | 1.382541e-8 |
GO:0002443 | leukocyte mediated immunity | 1.403430e-8 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.316744e-8 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 3.264733e-8 |
GO:0002688 | regulation of leukocyte chemotaxis | 4.125408e-8 |
GO:0034763 | negative regulation of transmembrane transport | 4.208794e-8 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 4.674189e-8 |
GO:0034762 | regulation of transmembrane transport | 4.744437e-8 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 5.334767e-8 |
GO:0010897 | negative regulation of triglyceride catabolic process | 5.334767e-8 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 6.295849e-8 |
GO:0051234 | establishment of localization | 7.303139e-8 |
GO:0002685 | regulation of leukocyte migration | 7.641393e-8 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 9.520810e-8 |
GO:0009895 | negative regulation of catabolic process | 9.861467e-8 |
GO:0046339 | diacylglycerol metabolic process | 1.212990e-7 |
GO:0002577 | regulation of antigen processing and presentation | 1.228545e-7 |
GO:0070536 | protein K63-linked deubiquitination | 1.248733e-7 |
GO:0051241 | negative regulation of multicellular organismal process | 1.330112e-7 |
GO:0002449 | lymphocyte mediated immunity | 1.332315e-7 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 1.396460e-7 |
GO:0042221 | response to chemical stimulus | 1.698467e-7 |
GO:0002579 | positive regulation of antigen processing and presentation | 2.166327e-7 |
GO:0006198 | cAMP catabolic process | 2.251592e-7 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 2.260390e-7 |
GO:0048002 | antigen processing and presentation of peptide antigen | 2.346093e-7 |
GO:0090209 | negative regulation of triglyceride metabolic process | 3.456999e-7 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 4.497534e-7 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 5.054511e-7 |
GO:0019882 | antigen processing and presentation | 5.330951e-7 |
GO:0055085 | transmembrane transport | 5.543818e-7 |
GO:0046058 | cAMP metabolic process | 5.759758e-7 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 6.629338e-7 |
GO:0035094 | response to nicotine | 6.755747e-7 |
GO:0006116 | NADH oxidation | 7.055339e-7 |
GO:0001818 | negative regulation of cytokine production | 8.352542e-7 |
GO:0045933 | positive regulation of muscle contraction | 9.400359e-7 |
GO:0006810 | transport | 9.667158e-7 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.048727e-6 |
GO:0016064 | immunoglobulin mediated immune response | 1.181594e-6 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 1.241214e-6 |
GO:0060760 | positive regulation of response to cytokine stimulus | 1.279564e-6 |
GO:0002252 | immune effector process | 1.321339e-6 |
GO:0006508 | proteolysis | 1.328823e-6 |
GO:0019724 | B cell mediated immunity | 1.640302e-6 |
GO:0050711 | negative regulation of interleukin-1 secretion | 1.827843e-6 |
GO:0050921 | positive regulation of chemotaxis | 1.839133e-6 |
GO:0050896 | response to stimulus | 2.094178e-6 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 2.392140e-6 |
GO:0042069 | regulation of catecholamine metabolic process | 2.681905e-6 |
GO:0009187 | cyclic nucleotide metabolic process | 2.874760e-6 |
GO:0032652 | regulation of interleukin-1 production | 2.922243e-6 |
GO:0090075 | relaxation of muscle | 3.119351e-6 |
GO:0015074 | DNA integration | 3.245886e-6 |
GO:0051223 | regulation of protein transport | 3.609279e-6 |
GO:0032369 | negative regulation of lipid transport | 3.645929e-6 |
GO:0032651 | regulation of interleukin-1 beta production | 3.678714e-6 |
GO:0045833 | negative regulation of lipid metabolic process | 3.779786e-6 |
GO:0007588 | excretion | 3.803217e-6 |
GO:0051049 | regulation of transport | 3.985464e-6 |
GO:0009719 | response to endogenous stimulus | 4.076902e-6 |
GO:0002821 | positive regulation of adaptive immune response | 4.147374e-6 |
GO:0032675 | regulation of interleukin-6 production | 4.485313e-6 |
GO:0042311 | vasodilation | 4.513231e-6 |
GO:0008211 | glucocorticoid metabolic process | 4.534427e-6 |
GO:0001817 | regulation of cytokine production | 4.599743e-6 |
GO:0007021 | tubulin complex assembly | 4.661142e-6 |
GO:0006749 | glutathione metabolic process | 4.729250e-6 |
GO:0070228 | regulation of lymphocyte apoptosis | 4.751860e-6 |
GO:0070307 | lens fiber cell development | 5.211839e-6 |
GO:0042420 | dopamine catabolic process | 5.261210e-6 |
GO:0032879 | regulation of localization | 5.609616e-6 |
GO:0007586 | digestion | 6.126824e-6 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 6.183552e-6 |
GO:0070141 | response to UV-A | 6.865091e-6 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 6.957290e-6 |
GO:0061024 | membrane organization | 7.082554e-6 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 7.937872e-6 |
GO:0070509 | calcium ion import | 8.549193e-6 |
GO:0019218 | regulation of steroid metabolic process | 8.754952e-6 |
GO:0014075 | response to amine stimulus | 8.779156e-6 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 9.122763e-6 |
GO:0006629 | lipid metabolic process | 9.378287e-6 |
GO:0051179 | localization | 9.927832e-6 |
GO:0031330 | negative regulation of cellular catabolic process | 1.004721e-5 |
GO:0002830 | positive regulation of type 2 immune response | 1.037526e-5 |
GO:0016044 | cellular membrane organization | 1.038623e-5 |
GO:0043242 | negative regulation of protein complex disassembly | 1.162390e-5 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 1.258524e-5 |
GO:0050848 | regulation of calcium-mediated signaling | 1.264903e-5 |
GO:0042053 | regulation of dopamine metabolic process | 1.427515e-5 |
GO:0031347 | regulation of defense response | 1.436150e-5 |
GO:0002034 | regulation of blood vessel size by renin-angiotensin | 1.460739e-5 |
GO:0014070 | response to organic cyclic compound | 1.484414e-5 |
GO:0001885 | endothelial cell development | 1.497839e-5 |
GO:0042424 | catecholamine catabolic process | 1.572720e-5 |
GO:0030834 | regulation of actin filament depolymerization | 1.594262e-5 |
GO:0032957 | inositol trisphosphate metabolic process | 1.634938e-5 |
GO:0010935 | regulation of macrophage cytokine production | 1.645284e-5 |
GO:0070201 | regulation of establishment of protein localization | 1.657159e-5 |
GO:0070508 | cholesterol import | 1.962107e-5 |
GO:0044062 | regulation of excretion | 2.204419e-5 |
GO:0002238 | response to molecule of fungal origin | 2.221771e-5 |
GO:0032386 | regulation of intracellular transport | 2.236586e-5 |
GO:0050729 | positive regulation of inflammatory response | 2.464768e-5 |
GO:0030835 | negative regulation of actin filament depolymerization | 2.485865e-5 |
GO:0010038 | response to metal ion | 2.544751e-5 |
GO:0006544 | glycine metabolic process | 2.558632e-5 |
GO:0044255 | cellular lipid metabolic process | 2.631991e-5 |
GO:0045987 | positive regulation of smooth muscle contraction | 2.654194e-5 |
GO:0048520 | positive regulation of behavior | 2.772541e-5 |
GO:0031349 | positive regulation of defense response | 2.895093e-5 |
GO:0045932 | negative regulation of muscle contraction | 3.106820e-5 |
GO:0032715 | negative regulation of interleukin-6 production | 3.107490e-5 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.135446e-5 |
GO:0071310 | cellular response to organic substance | 3.154891e-5 |
GO:0032101 | regulation of response to external stimulus | 3.414567e-5 |
GO:0046890 | regulation of lipid biosynthetic process | 3.814983e-5 |
GO:0048146 | positive regulation of fibroblast proliferation | 3.831844e-5 |
GO:0007015 | actin filament organization | 3.905147e-5 |
GO:2000107 | negative regulation of leukocyte apoptosis | 4.107410e-5 |
GO:0006952 | defense response | 4.215324e-5 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 4.246953e-5 |
GO:2000484 | positive regulation of interleukin-8 secretion | 4.246953e-5 |
GO:0030334 | regulation of cell migration | 4.296223e-5 |
GO:0006651 | diacylglycerol biosynthetic process | 4.583930e-5 |
GO:0030574 | collagen catabolic process | 4.604229e-5 |
GO:0050707 | regulation of cytokine secretion | 4.673913e-5 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 4.702324e-5 |
GO:0002741 | positive regulation of cytokine secretion involved in immune response | 4.758595e-5 |
GO:0050995 | negative regulation of lipid catabolic process | 4.871770e-5 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.957454e-5 |
GO:0034380 | high-density lipoprotein particle assembly | 4.965373e-5 |
GO:0002902 | regulation of B cell apoptosis | 5.060412e-5 |
GO:0032963 | collagen metabolic process | 5.067229e-5 |
GO:0071418 | cellular response to amine stimulus | 5.165422e-5 |
GO:0016311 | dephosphorylation | 5.201896e-5 |
GO:0042558 | pteridine-containing compound metabolic process | 5.202799e-5 |
GO:0019637 | organophosphate metabolic process | 5.281616e-5 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.289517e-5 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 5.632151e-5 |
GO:0006955 | immune response | 5.748211e-5 |
GO:0009123 | nucleoside monophosphate metabolic process | 5.760956e-5 |
GO:0032602 | chemokine production | 5.798103e-5 |
GO:0000072 | M phase specific microtubule process | 5.816532e-5 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.908739e-5 |
GO:0032375 | negative regulation of cholesterol transport | 6.098089e-5 |
GO:0046069 | cGMP catabolic process | 6.477491e-5 |
GO:0051693 | actin filament capping | 6.587803e-5 |
GO:0006575 | cellular modified amino acid metabolic process | 6.698876e-5 |
GO:0040017 | positive regulation of locomotion | 6.716936e-5 |
GO:0008637 | apoptotic mitochondrial changes | 7.129587e-5 |
GO:0010863 | positive regulation of phospholipase C activity | 7.341779e-5 |
GO:0033598 | mammary gland epithelial cell proliferation | 7.438555e-5 |
GO:0051084 | 'de novo' posttranslational protein folding | 7.489175e-5 |
GO:2000145 | regulation of cell motility | 7.697217e-5 |
GO:0019216 | regulation of lipid metabolic process | 7.951865e-5 |
GO:0032642 | regulation of chemokine production | 8.122763e-5 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 8.377760e-5 |
GO:0016090 | prenol metabolic process | 8.436080e-5 |
GO:0050706 | regulation of interleukin-1 beta secretion | 8.600110e-5 |
GO:0006958 | complement activation, classical pathway | 8.616874e-5 |
GO:2000273 | positive regulation of receptor activity | 8.664088e-5 |
GO:0046688 | response to copper ion | 8.678521e-5 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 8.868770e-5 |
GO:0070887 | cellular response to chemical stimulus | 8.960556e-5 |
GO:0071230 | cellular response to amino acid stimulus | 8.963525e-5 |
GO:0006897 | endocytosis | 9.172788e-5 |
GO:0043244 | regulation of protein complex disassembly | 9.567370e-5 |
GO:0043627 | response to estrogen stimulus | 9.655316e-5 |
GO:0006760 | folic acid-containing compound metabolic process | 9.657898e-5 |
GO:2000147 | positive regulation of cell motility | 9.838595e-5 |
GO:0050668 | positive regulation of homocysteine metabolic process | 1.002616e-4 |
GO:0045963 | negative regulation of dopamine metabolic process | 1.002616e-4 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 1.002616e-4 |
GO:0015862 | uridine transport | 1.034434e-4 |
GO:0006883 | cellular sodium ion homeostasis | 1.034434e-4 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1.066742e-4 |
GO:0071229 | cellular response to acid | 1.082801e-4 |
GO:0051403 | stress-activated MAPK cascade | 1.103240e-4 |
GO:0032880 | regulation of protein localization | 1.123671e-4 |
GO:0006957 | complement activation, alternative pathway | 1.146270e-4 |
GO:2000106 | regulation of leukocyte apoptosis | 1.150464e-4 |
GO:0032488 | Cdc42 protein signal transduction | 1.157568e-4 |
GO:0032691 | negative regulation of interleukin-1 beta production | 1.201447e-4 |
GO:0002237 | response to molecule of bacterial origin | 1.214146e-4 |
GO:0002684 | positive regulation of immune system process | 1.241962e-4 |
GO:0003073 | regulation of systemic arterial blood pressure | 1.255723e-4 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 1.307288e-4 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 1.307288e-4 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 1.307288e-4 |
GO:0008065 | establishment of blood-nerve barrier | 1.307288e-4 |
GO:0070309 | lens fiber cell morphogenesis | 1.349177e-4 |
GO:0010035 | response to inorganic substance | 1.386668e-4 |
GO:0060067 | cervix development | 1.399839e-4 |
GO:0046697 | decidualization | 1.425769e-4 |
GO:0007202 | activation of phospholipase C activity | 1.444195e-4 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.469935e-4 |
GO:0030335 | positive regulation of cell migration | 1.489541e-4 |
GO:0048149 | behavioral response to ethanol | 1.523117e-4 |
GO:0010193 | response to ozone | 1.573899e-4 |
GO:0060191 | regulation of lipase activity | 1.575362e-4 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 1.587550e-4 |
GO:0005979 | regulation of glycogen biosynthetic process | 1.623735e-4 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 1.633741e-4 |
GO:0009310 | amine catabolic process | 1.664381e-4 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 1.672098e-4 |
GO:0050850 | positive regulation of calcium-mediated signaling | 1.704822e-4 |
GO:0045840 | positive regulation of mitosis | 1.747661e-4 |
GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis | 1.755567e-4 |
GO:0050704 | regulation of interleukin-1 secretion | 1.756762e-4 |
GO:0042402 | cellular biogenic amine catabolic process | 1.756762e-4 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 1.767567e-4 |
GO:0010518 | positive regulation of phospholipase activity | 1.789821e-4 |
GO:0032680 | regulation of tumor necrosis factor production | 1.832026e-4 |
GO:0051764 | actin crosslink formation | 1.844850e-4 |
GO:0090037 | positive regulation of protein kinase C signaling cascade | 1.844850e-4 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.844850e-4 |
GO:0071635 | negative regulation of transforming growth factor beta production | 1.846163e-4 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 1.854945e-4 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 1.876795e-4 |
GO:0022900 | electron transport chain | 1.884705e-4 |
GO:0023052 | signaling | 1.911162e-4 |
GO:0042493 | response to drug | 1.930673e-4 |
GO:0001300 | chronological cell aging | 1.959362e-4 |
GO:0071417 | cellular response to organic nitrogen | 1.964701e-4 |
GO:0002250 | adaptive immune response | 1.991057e-4 |
GO:0010951 | negative regulation of endopeptidase activity | 2.003808e-4 |
GO:0060806 | negative regulation of cell differentiation involved in embryonic placenta development | 2.117508e-4 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 2.123131e-4 |
GO:0051270 | regulation of cellular component movement | 2.134318e-4 |
GO:0051657 | maintenance of organelle location | 2.161409e-4 |
GO:0090257 | regulation of muscle system process | 2.179182e-4 |
GO:0050795 | regulation of behavior | 2.192825e-4 |
GO:0070189 | kynurenine metabolic process | 2.194265e-4 |
GO:0010873 | positive regulation of cholesterol esterification | 2.194349e-4 |
GO:0051488 | activation of anaphase-promoting complex activity | 2.202018e-4 |
GO:0009607 | response to biotic stimulus | 2.250296e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.266461e-4 |
GO:0050727 | regulation of inflammatory response | 2.283471e-4 |
GO:0070229 | negative regulation of lymphocyte apoptosis | 2.296477e-4 |
GO:0030837 | negative regulation of actin filament polymerization | 2.306030e-4 |
GO:0009617 | response to bacterium | 2.341221e-4 |
GO:0045651 | positive regulation of macrophage differentiation | 2.352599e-4 |
GO:0006477 | protein sulfation | 2.364701e-4 |
GO:0002019 | regulation of renal output by angiotensin | 2.382624e-4 |
GO:0032692 | negative regulation of interleukin-1 production | 2.390378e-4 |
GO:0070875 | positive regulation of glycogen metabolic process | 2.436614e-4 |
GO:0030300 | regulation of intestinal cholesterol absorption | 2.524548e-4 |
GO:0071545 | inositol phosphate catabolic process | 2.569318e-4 |
GO:0008207 | C21-steroid hormone metabolic process | 2.591238e-4 |
GO:0090022 | regulation of neutrophil chemotaxis | 2.603310e-4 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 2.628987e-4 |
GO:0043279 | response to alkaloid | 2.632871e-4 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 2.643468e-4 |
GO:0042177 | negative regulation of protein catabolic process | 2.648120e-4 |
GO:0045940 | positive regulation of steroid metabolic process | 2.683402e-4 |
GO:0032781 | positive regulation of ATPase activity | 2.699083e-4 |
GO:0019374 | galactolipid metabolic process | 2.710435e-4 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 2.756388e-4 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 2.794884e-4 |
GO:0071219 | cellular response to molecule of bacterial origin | 2.806623e-4 |
GO:0051272 | positive regulation of cellular component movement | 2.829797e-4 |
GO:0032677 | regulation of interleukin-8 production | 2.871896e-4 |
GO:0010872 | regulation of cholesterol esterification | 2.924997e-4 |
GO:0007154 | cell communication | 2.969669e-4 |
GO:0001812 | positive regulation of type I hypersensitivity | 3.003429e-4 |
GO:0050708 | regulation of protein secretion | 3.011722e-4 |
GO:0003218 | cardiac left ventricle formation | 3.034587e-4 |
GO:0007290 | spermatid nucleus elongation | 3.034587e-4 |
GO:0032649 | regulation of interferon-gamma production | 3.235993e-4 |
GO:0072668 | tubulin complex biogenesis | 3.254922e-4 |
GO:0071321 | cellular response to cGMP | 3.272812e-4 |
GO:0001101 | response to acid | 3.274197e-4 |
GO:0046855 | inositol phosphate dephosphorylation | 3.288479e-4 |
GO:0006950 | response to stress | 3.344462e-4 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 3.368904e-4 |
GO:0051716 | cellular response to stimulus | 3.501395e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 3.505828e-4 |
GO:0045988 | negative regulation of striated muscle contraction | 3.515557e-4 |
GO:0052572 | response to host immune response | 3.536048e-4 |
GO:0034097 | response to cytokine stimulus | 3.540452e-4 |
GO:0032496 | response to lipopolysaccharide | 3.619024e-4 |
GO:0006664 | glycolipid metabolic process | 3.650100e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 3.723611e-4 |
GO:0009166 | nucleotide catabolic process | 3.979682e-4 |
GO:0001759 | organ induction | 4.181258e-4 |
GO:0032227 | negative regulation of synaptic transmission, dopaminergic | 4.183740e-4 |
GO:0071495 | cellular response to endogenous stimulus | 4.258125e-4 |
GO:0070306 | lens fiber cell differentiation | 4.383695e-4 |
GO:0040012 | regulation of locomotion | 4.432016e-4 |
GO:0008616 | queuosine biosynthetic process | 4.451667e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 4.556304e-4 |
GO:0046700 | heterocycle catabolic process | 4.563072e-4 |
GO:0007165 | signal transduction | 4.583134e-4 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 4.650010e-4 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 4.711188e-4 |
GO:0060341 | regulation of cellular localization | 4.744899e-4 |
GO:0046456 | icosanoid biosynthetic process | 4.790811e-4 |
GO:0044270 | cellular nitrogen compound catabolic process | 4.823993e-4 |
GO:0051646 | mitochondrion localization | 4.837474e-4 |
GO:0002339 | B cell selection | 4.908437e-4 |
GO:0051964 | negative regulation of synapse assembly | 4.908437e-4 |
GO:0031272 | regulation of pseudopodium assembly | 5.329460e-4 |
GO:0051055 | negative regulation of lipid biosynthetic process | 5.431280e-4 |
GO:0043086 | negative regulation of catalytic activity | 5.463916e-4 |
GO:0031915 | positive regulation of synaptic plasticity | 5.731044e-4 |
GO:0032930 | positive regulation of superoxide anion generation | 5.770351e-4 |
GO:0035150 | regulation of tube size | 5.803851e-4 |
GO:0006956 | complement activation | 5.877960e-4 |
GO:0042306 | regulation of protein import into nucleus | 5.884065e-4 |
GO:0050710 | negative regulation of cytokine secretion | 6.101750e-4 |
GO:0019058 | viral infectious cycle | 6.101750e-4 |
GO:0044058 | regulation of digestive system process | 6.110304e-4 |
GO:0006470 | protein dephosphorylation | 6.169432e-4 |
GO:0090076 | relaxation of skeletal muscle | 6.221990e-4 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 6.221990e-4 |
GO:0010948 | negative regulation of cell cycle process | 6.302981e-4 |
GO:0035556 | intracellular signal transduction | 6.307078e-4 |
GO:0051659 | maintenance of mitochondrion location | 6.308386e-4 |
GO:0051386 | regulation of nerve growth factor receptor signaling pathway | 6.346835e-4 |
GO:0048584 | positive regulation of response to stimulus | 6.392546e-4 |
GO:0008286 | insulin receptor signaling pathway | 6.517897e-4 |
GO:0010243 | response to organic nitrogen | 6.522093e-4 |
GO:0071216 | cellular response to biotic stimulus | 6.547275e-4 |
GO:0035813 | regulation of renal sodium excretion | 6.567800e-4 |
GO:0030162 | regulation of proteolysis | 6.578224e-4 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 6.601090e-4 |
GO:2000647 | negative regulation of stem cell proliferation | 6.645502e-4 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 6.645502e-4 |
GO:0035921 | desmosome disassembly | 6.645502e-4 |
GO:0010839 | negative regulation of keratinocyte proliferation | 6.645502e-4 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 6.652534e-4 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 6.652534e-4 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 6.652534e-4 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 6.652534e-4 |
GO:0060210 | metestrus | 6.652534e-4 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 6.652534e-4 |
GO:0050880 | regulation of blood vessel size | 6.693825e-4 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 6.758042e-4 |
GO:0034122 | negative regulation of toll-like receptor signaling pathway | 6.758042e-4 |
GO:0050920 | regulation of chemotaxis | 6.846998e-4 |
GO:0009063 | cellular amino acid catabolic process | 6.883235e-4 |
GO:0045835 | negative regulation of meiosis | 7.077497e-4 |
GO:0042104 | positive regulation of activated T cell proliferation | 7.125669e-4 |
GO:0009056 | catabolic process | 7.324852e-4 |
GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly | 7.349178e-4 |
GO:0002115 | store-operated calcium entry | 7.349178e-4 |
GO:0006690 | icosanoid metabolic process | 7.351605e-4 |
GO:0016486 | peptide hormone processing | 7.356780e-4 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 7.368527e-4 |
GO:0072594 | establishment of protein localization to organelle | 7.496911e-4 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 7.569057e-4 |
GO:0060290 | transdifferentiation | 7.569057e-4 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 7.569057e-4 |
GO:0042742 | defense response to bacterium | 7.593797e-4 |
GO:0022904 | respiratory electron transport chain | 7.603914e-4 |
GO:0072521 | purine-containing compound metabolic process | 7.688313e-4 |
GO:0070613 | regulation of protein processing | 7.801147e-4 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 7.853987e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 8.062748e-4 |
GO:0001932 | regulation of protein phosphorylation | 8.278151e-4 |
GO:0006644 | phospholipid metabolic process | 8.323420e-4 |
GO:0002700 | regulation of production of molecular mediator of immune response | 8.569174e-4 |
GO:0051246 | regulation of protein metabolic process | 8.715619e-4 |
GO:0006643 | membrane lipid metabolic process | 8.873367e-4 |
GO:0046655 | folic acid metabolic process | 9.113039e-4 |
GO:0030198 | extracellular matrix organization | 9.117150e-4 |
GO:0032355 | response to estradiol stimulus | 9.230005e-4 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 9.309542e-4 |
GO:0022417 | protein maturation by protein folding | 9.309542e-4 |
GO:0001835 | blastocyst hatching | 9.333820e-4 |
GO:0051494 | negative regulation of cytoskeleton organization | 9.362749e-4 |
GO:0061037 | negative regulation of cartilage development | 9.441561e-4 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 9.653560e-4 |
GO:0006195 | purine nucleotide catabolic process | 9.751650e-4 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 9.779506e-4 |
GO:0009629 | response to gravity | 9.994011e-4 |
GO:0045047 | protein targeting to ER | 1.015841e-3 |
GO:0002697 | regulation of immune effector process | 1.017161e-3 |
GO:0006937 | regulation of muscle contraction | 1.019040e-3 |
GO:0043434 | response to peptide hormone stimulus | 1.020516e-3 |
GO:0019067 | viral assembly, maturation, egress, and release | 1.021010e-3 |
GO:0009725 | response to hormone stimulus | 1.040793e-3 |
GO:0050790 | regulation of catalytic activity | 1.053638e-3 |
GO:0006665 | sphingolipid metabolic process | 1.064223e-3 |
GO:0050709 | negative regulation of protein secretion | 1.068201e-3 |
GO:0008654 | phospholipid biosynthetic process | 1.101556e-3 |
GO:0051222 | positive regulation of protein transport | 1.104163e-3 |
GO:0010269 | response to selenium ion | 1.107889e-3 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 1.110913e-3 |
GO:0031657 | regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.119588e-3 |
GO:0006620 | posttranslational protein targeting to membrane | 1.129640e-3 |
GO:0050776 | regulation of immune response | 1.134198e-3 |
GO:0050878 | regulation of body fluid levels | 1.147059e-3 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 1.147570e-3 |
GO:0032908 | regulation of transforming growth factor beta1 production | 1.155132e-3 |
GO:0002526 | acute inflammatory response | 1.168459e-3 |
GO:0050912 | detection of chemical stimulus involved in sensory perception of taste | 1.175390e-3 |
GO:0045471 | response to ethanol | 1.180792e-3 |
GO:0001736 | establishment of planar polarity | 1.215100e-3 |
GO:0002540 | leukotriene production involved in inflammatory response | 1.233736e-3 |
GO:0046340 | diacylglycerol catabolic process | 1.246418e-3 |
GO:0051592 | response to calcium ion | 1.248681e-3 |
GO:0051961 | negative regulation of nervous system development | 1.251990e-3 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 1.258192e-3 |
GO:0001935 | endothelial cell proliferation | 1.263260e-3 |
GO:0072539 | T-helper 17 cell differentiation | 1.266125e-3 |
GO:0032661 | regulation of interleukin-18 production | 1.266125e-3 |
GO:0006083 | acetate metabolic process | 1.266125e-3 |
GO:0045446 | endothelial cell differentiation | 1.271883e-3 |
GO:0010761 | fibroblast migration | 1.275846e-3 |
GO:0046466 | membrane lipid catabolic process | 1.284663e-3 |
GO:0032459 | regulation of protein oligomerization | 1.284663e-3 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 1.294351e-3 |
GO:0006672 | ceramide metabolic process | 1.338494e-3 |
GO:0090066 | regulation of anatomical structure size | 1.347114e-3 |
GO:0060591 | chondroblast differentiation | 1.368536e-3 |
GO:0051896 | regulation of protein kinase B signaling cascade | 1.399624e-3 |
GO:0043200 | response to amino acid stimulus | 1.403171e-3 |
GO:0071363 | cellular response to growth factor stimulus | 1.407836e-3 |
GO:0046006 | regulation of activated T cell proliferation | 1.408346e-3 |
GO:0051135 | positive regulation of NK T cell activation | 1.412596e-3 |
GO:0071634 | regulation of transforming growth factor beta production | 1.434114e-3 |
GO:0042840 | D-glucuronate catabolic process | 1.498301e-3 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 1.498301e-3 |
GO:0003096 | renal sodium ion transport | 1.498301e-3 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 1.498301e-3 |
GO:0032782 | bile acid secretion | 1.498301e-3 |
GO:0032387 | negative regulation of intracellular transport | 1.500730e-3 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 1.509610e-3 |
GO:0042396 | phosphagen biosynthetic process | 1.516297e-3 |
GO:0022415 | viral reproductive process | 1.520113e-3 |
GO:0060068 | vagina development | 1.524389e-3 |
GO:0009628 | response to abiotic stimulus | 1.534246e-3 |
GO:0046686 | response to cadmium ion | 1.536178e-3 |
GO:0050810 | regulation of steroid biosynthetic process | 1.544024e-3 |
GO:0006406 | mRNA export from nucleus | 1.544941e-3 |
GO:0070340 | detection of bacterial lipopeptide | 1.571794e-3 |
GO:0002828 | regulation of type 2 immune response | 1.596317e-3 |
GO:0006568 | tryptophan metabolic process | 1.613541e-3 |
GO:0034382 | chylomicron remnant clearance | 1.630823e-3 |
GO:0010639 | negative regulation of organelle organization | 1.632132e-3 |
GO:0034377 | plasma lipoprotein particle assembly | 1.634632e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.642024e-3 |
GO:0001516 | prostaglandin biosynthetic process | 1.644713e-3 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 1.644858e-3 |
GO:0031017 | exocrine pancreas development | 1.648618e-3 |
GO:0015802 | basic amino acid transport | 1.667064e-3 |
GO:0032425 | positive regulation of mismatch repair | 1.700619e-3 |
GO:0051451 | myoblast migration | 1.700619e-3 |
GO:0010912 | positive regulation of isomerase activity | 1.700619e-3 |
GO:0006939 | smooth muscle contraction | 1.715482e-3 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.725730e-3 |
GO:2000146 | negative regulation of cell motility | 1.739030e-3 |
GO:0032501 | multicellular organismal process | 1.759366e-3 |
GO:0051461 | positive regulation of corticotropin secretion | 1.766611e-3 |
GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 1.766611e-3 |
GO:0051445 | regulation of meiotic cell cycle | 1.791546e-3 |
GO:0070305 | response to cGMP | 1.796746e-3 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.796746e-3 |
GO:0009071 | serine family amino acid catabolic process | 1.807905e-3 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 1.813170e-3 |
GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste | 1.813170e-3 |
GO:0002275 | myeloid cell activation involved in immune response | 1.818575e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.824425e-3 |
GO:0002885 | positive regulation of hypersensitivity | 1.824425e-3 |
GO:0019441 | tryptophan catabolic process to kynurenine | 1.826220e-3 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 1.831918e-3 |
GO:0002675 | positive regulation of acute inflammatory response | 1.858211e-3 |
GO:0010565 | regulation of cellular ketone metabolic process | 1.876758e-3 |
GO:0032012 | regulation of ARF protein signal transduction | 1.885858e-3 |
GO:0006163 | purine nucleotide metabolic process | 1.893303e-3 |
GO:0006986 | response to unfolded protein | 1.896208e-3 |
GO:0050994 | regulation of lipid catabolic process | 1.919489e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 1.926581e-3 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 1.934948e-3 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 1.934948e-3 |
GO:0061077 | chaperone-mediated protein folding | 1.978819e-3 |
GO:0006693 | prostaglandin metabolic process | 1.989575e-3 |
GO:0034109 | homotypic cell-cell adhesion | 2.029474e-3 |
GO:0070972 | protein localization in endoplasmic reticulum | 2.055633e-3 |
GO:0052556 | positive regulation by symbiont of host immune response | 2.083748e-3 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 2.083748e-3 |
GO:0052509 | positive regulation by symbiont of host defense response | 2.083748e-3 |